» Authors » Daisuke Sugiyama

Daisuke Sugiyama

Explore the profile of Daisuke Sugiyama including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 302
Citations 7178
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Nishikawa T, Miyamatsu N, Higashiyama A, Kubota Y, Nishida Y, Hirata T, et al.
Environ Health Prev Med . 2024 Nov; 29:62. PMID: 39496441
Background: Dehydration, a risk factor for ischemic cerebrovascular diseases, is common in summer; however, the incidence of ischemic diseases is not necessarily higher in summer. Therefore, this study aimed to...
12.
Matsumoto M, Harada S, Ikuta H, Iida M, Kato S, Sata M, et al.
Pharmacoepidemiol Drug Saf . 2024 Aug; 33(8):e5855. PMID: 39145400
Purpose: Hypertension (HT), dyslipidemia (DL), and diabetes mellitus (DM) are major risk factors for cardiovascular diseases. Despite the wide availability of medications to reduce this risk, poor adherence to medications...
13.
Jin Z, Sugiyama D, Higo F, Hirata T, Kobayashi O, Morimatsu H, et al.
Korean J Anesthesiol . 2024 Jun; 77(5):565-569. PMID: 38894684
Background: Elderly patients with femoral neck fractures, particularly those with severe comorbidities or living in regions with limited medical resources, may experience delays in surgical treatment. Although the benefits of...
14.
Ishibashi Y, Harada S, Eitaki Y, Kurihara A, Kato S, Kuwabara K, et al.
Environ Health Prev Med . 2024 Mar; 29:22. PMID: 38556356
Background: The application of metabolomics-based profiles in environmental epidemiological studies is a promising approach to refine the process of health risk assessment. We aimed to identify potential metabolomics-based profiles in...
15.
Tsutsumi S, Takano A, Usami T, Kumakura Y, Kanazawa Y, Takebayashi T, et al.
J Subst Use Addict Treat . 2024 Mar; 162:209347. PMID: 38494050
Introduction: Individuals involved with the criminal justice system face challenges in receiving and maintaining substance use disorder (SUD) treatment and support. Although telephone monitoring (TM) could reduce these barriers, data...
16.
Hirata A, Harada S, Iida M, Kurihara A, Fukai K, Kuwabara K, et al.
J Atheroscler Thromb . 2024 Feb; 31(7):1031-1047. PMID: 38311416
Aims: Nonalcoholic fatty liver disease (NAFLD) is known to be associated with atherosclerosis. This study focused on upstream changes in the process by which NAFLD leads to atherosclerosis. The study...
17.
Miyake A, Harada S, Sugiyama D, Matsumoto M, Hirata A, Miyagawa N, et al.
Metabolites . 2024 Jan; 14(1). PMID: 38276312
Studies examining long-term longitudinal metabolomic data and their reliability in large-scale populations are limited. Therefore, we aimed to evaluate the reliability of repeated measurements of plasma metabolites in a prospective...
18.
Harada S, Iida M, Miyagawa N, Hirata A, Kuwabara K, Matsumoto M, et al.
J Epidemiol . 2024 Jan; 34(8):393-401. PMID: 38191178
The Tsuruoka Metabolomics Cohort Study (TMCS) is an ongoing population-based cohort study being conducted in the rural area of Yamagata Prefecture, Japan. This study aimed to enhance the precision prevention...
19.
Sasai M, Okamoto M, Tanigawa S, Okada S, Sugiyama D, Myoui A
Regen Ther . 2024 Jan; 25:85-91. PMID: 38187516
Introduction: The Act on the Safety of Regenerative Medicine enforced in Japan in 2014, regulates the manufacture of cellular processed products. However, with regards to the manufacturing facilities at medical...
20.
Kato Y, Shinozaki T, Sugiyama D, Taguchi A, Nagata S
Hum Vaccin Immunother . 2023 Dec; 19(3):2296737. PMID: 38112133
Although COVID-19 vaccination was approved for younger children in Japan in October 2022, uptake rates remain critically low. This study aimed to investigate Japanese parents' intentions, hesitators' probability of positive...